Literature DB >> 3253136

The significance of ophthalmological symptoms in idiopathic blepharospasm.

J S Elston1, C D Marsden, F Grandas, N P Quinn.   

Abstract

Two hundred and seventy-two patients with idiopathic blepharospasm were reviewed to establish the role of local eye disease in their illness. The majority of patients (57%) had symptoms at the onset of their illness such as dryness of the eyes, grittiness, irritation or photophobia suggesting eye lid or ocular surface disease. Detailed ophthalmological examination at the time of presentation had been carried out in 170 of the 272 cases; 64% of these patients had ocular symptoms, and 40% had demonstrable ocular surface or eye lid pathology. Such pathology was usually bilateral, chronic and resistant to local treatment. Blepharospasm developed in these patients after a long latent period, often of many years. Unilateral pathology was acute, normally responded well to local treatment, but was followed by the development of bilateral blepharospasm usually within six months. Amongst all 272 patients, those without ocular symptoms at presentation rarely developed them subsequently; if they did, there were no abnormal signs. The data suggest that ophthalmological disorders may trigger idiopathic blepharospasm in a substantial proportion of cases predisposed to develop this condition.

Entities:  

Mesh:

Year:  1988        PMID: 3253136     DOI: 10.1038/eye.1988.79

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  13 in total

1.  Dry eye, blinking, and blepharospasm.

Authors:  Craig Evinger; Jian-Bin Bao; Alice S Powers; Iris S Kassem; Edward J Schicatano; Victor M Henriquez; Kavita R Peshori
Journal:  Mov Disord       Date:  2002       Impact factor: 10.338

2.  A new variant of blepharospasm.

Authors:  J S Elston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

Review 3.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

Review 4.  Animal models of focal dystonia.

Authors:  Craig Evinger
Journal:  NeuroRx       Date:  2005-07

5.  The management of blepharospasm and hemifacial spasm.

Authors:  J S Elston
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

6.  Botulinum toxin type A therapy for blepharospasm.

Authors:  Gonçalo S Duarte; Filipe B Rodrigues; Raquel E Marques; Mafalda Castelão; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2020-11-19

7.  Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB.

Authors:  Yoshihiko Isshiki; Hiroto Ishikawa; Osamu Mimura
Journal:  Jpn J Ophthalmol       Date:  2016-08-08       Impact factor: 2.447

Review 8.  Primary blepharospasm: diagnosis and management.

Authors:  Giovanni Defazio; Paolo Livrea
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Pretarsal application of botulinum toxin for treatment of blepharospasm.

Authors:  M Aramideh; B W Ongerboer de Visser; J W Brans; J H Koelman; J D Speelman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

10.  Animal models for investigating benign essential blepharospasm.

Authors:  Craig Evinger
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.